newsfilter
← Latest News
Business Wire·

Satellos Announces Upcoming Presentation at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

- Satellos plans to highlight Phase 1 safety and PK data for SAT-3247 Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic